As of the close on Friday,$S&P/ASX 200(XJO.AU)$ closed at 6,976.50 points, down 0.02% in the past 5 days.
1. $Neuren Pharma(NEU.AU)$ adds about 40% due to higher royalties from DAYBUE
$Neuren Pharma(NEU.AU)$ made the second winner in ASX last week, rising 19.75%.
It continues to rise this week with expectations of higher royalties from escalating sales of DAYBUE.
NEU granted $ACADIA Pharmaceuticals(ACAD)$ an exclusive global license of this drug.
2. $Light & Wonder Inc(LNW.AU)$ , the gaming company, rises 11.61% and may go higher next week
EPS: 81 cents, beating by 107%
Achieve 10 consecutive quarters of revenue growth, a 13% YoY increase.
Announce key partnerships with Netflix and Betsson.
3. $JAMES HARDIE INDUSTRIES-CDI(JHX.AU)$ James Hardie, the world’s largest fibre cement maker, posts surging profits and announces buyback.
Profits were driven by a marked increase in average sales prices (ASP) for all its international divisions.
Share buyback of US$250 mln over the next year, replacing dividends until October 2024.
4. $IRESS LTD(IRE.AU)$ goes up 7.29%
Iress Limited engages in the designing and developing software and services for the financial services industry.
$IRESS LTD(IRE.AU)$ has been declining after its earnings in August and rebound since Monday.
5. $RAMSAY HEALTH CARE LIMITED(RHC.AU)$ increases 6.37% after its branch received a $1.5 bln takeover offer
Columbia Asia, supported by TPG, is reportedly the leading contender to acquire Malaysia's Ramsay Sime Darby Health Care for $1.5 bln.
If successful, it would mark the largest healthcare acquisition in Southeast Asia since 2019.
Comments